Wells Fargo
MLNT

Wells Fargo’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-4
Closed 6805
2019
Q4
$0 Sell
4
-3
-43% ﹤0.01% 6455
2019
Q3
$0 Sell
7
-509
-99% ﹤0.01% 6408
2019
Q2
$4K Sell
516
-3,293
-86% -$25.5K ﹤0.01% 5661
2019
Q1
$13K Sell
3,809
-15,719
-80% -$53.6K ﹤0.01% 5493
2018
Q4
$16K Sell
19,528
-8,811
-31% -$7.22K ﹤0.01% 5475
2018
Q3
$113K Buy
28,339
+4,092
+17% +$16.3K ﹤0.01% 5082
2018
Q2
$155K Buy
24,247
+18,268
+306% +$117K ﹤0.01% 4964
2018
Q1
$45K Sell
5,979
-1,810
-23% -$13.6K ﹤0.01% 5306
2017
Q4
$123K Buy
+7,789
New +$123K ﹤0.01% 5008